Zhejiang Jiuzhou Pharmaceutical Co. Ltd. provided earnings guidance for the full year of 2017. The company predicts an increase of between 50.00% and 70.00% compared with the same period of the year before in the net profit owned by shareholders of the listed company before cost amortization after excluding extraordinary profit and loss in 2017. The company will see an increase of between RMB 33.44 and RMB 55.74 million in its net profit owned by shareholders of the listed company in 2017 compared with the same period of the year before, with a year-on-year increase of between 30.00% and 50.00% (based on the disclosed statistics according to relevant regulations). The net profit belonging to shareholders of the listed company after excluding extraordinary profit and loss will increase by between RMB 23.44 million and RMB 45.74 million compared with the same period of the year before, with an increase of between 24.62% and 48.05% (based on the disclosed statistics according to relevant regulations).